2025
2024 Update of the North American Consensus Guidelines for Pediatric Administered Radiopharmaceutical Activities.
Treves S, Fahey F, Ferrer Valencia V, Burchell N, Burton C, Czachowski M, Grant F, Lai H, Lim R, Nadel H, Pampaloni M, Pandit-Taskar N, Parisi M, Seghers V, Shah S, Shulkin B, States L, Vali R, Yoo D, Zukotynski K. 2024 Update of the North American Consensus Guidelines for Pediatric Administered Radiopharmaceutical Activities. Journal Of Nuclear Medicine Technology 2025, 53: 193-197. PMID: 40664486, DOI: 10.2967/jnmt.125.270161.Peer-Reviewed Original ResearchConceptsNorth American consensus guidelinesAmerican consensus guidelinesConsensus guidelinesNuclear medicine expertsRadiopharmaceutical activityPediatric nuclear medicinePractice of pediatric nuclear medicineNuclear medicineAdministered radiopharmaceutical activityRadiopharmaceutical agentRoutine usePET imagingClinical practiceDiagnostic nuclear medicineMedicine expertsWorking GroupImpact of advancesPETGuidelinesAn Investigation on Cross-Tracer Generalizability of Deep Learning-Based PET Attenuation Correction
Hou J, Chen T, Zhou Y, Chen X, Xie H, Liu Q, Xia M, Panin V, Toyonaga T, Liu C, Zhou B. An Investigation on Cross-Tracer Generalizability of Deep Learning-Based PET Attenuation Correction. IEEE Transactions On Radiation And Plasma Medical Sciences 2025, PP: 1-1. DOI: 10.1109/trpms.2025.3566630.Peer-Reviewed Original ResearchAttenuation mapAttenuation correctionPET attenuation correctionAC PET imagesPET imagingQuantitative PET imagingPET reconstructionNon-attenuationAttenuation-corrected (ACTracer typeRadiation doseDL modelsDeep learning (DL)-based methodsMLAADL model trainingCorrectionPET signalNetwork performanceCompetitive performanceModel trainingAttenuationRadiationTracer activityM-CTPET
2022
PET Imaging in Animal Models of Alzheimer’s Disease
Chen B, Marquez-Nostra B, Belitzky E, Toyonaga T, Tong J, Huang Y, Cai Z. PET Imaging in Animal Models of Alzheimer’s Disease. Frontiers In Neuroscience 2022, 16: 872509. PMID: 35685772, PMCID: PMC9171374, DOI: 10.3389/fnins.2022.872509.Peer-Reviewed Original ResearchAnimal modelsPreclinical PET imagingPET imagingOngoing clinical trialsΒ-amyloid plaquesAnimal model developmentPathogenesis/progressionTau-PETClinical trialsTau tanglesTherapeutic effectAD modelNovel treatmentsAlzheimer's diseaseDrug action mechanismsDiseaseAction mechanismImagingPatientsPETPlaquesProgressionTrialsAntemortemIdentifying the individual metabolic abnormities from a systemic perspective using whole-body PET imaging
Sun T, Wang Z, Wu Y, Gu F, Li X, Bai Y, Shen C, Hu Z, Liang D, Liu X, Zheng H, Yang Y, El Fakhri G, Zhou Y, Wang M. Identifying the individual metabolic abnormities from a systemic perspective using whole-body PET imaging. European Journal Of Nuclear Medicine And Molecular Imaging 2022, 49: 2994-3004. PMID: 35567627, PMCID: PMC9106794, DOI: 10.1007/s00259-022-05832-7.Peer-Reviewed Original ResearchConceptsPET imagingNormal control databaseTotal-body imagingWhole-body PET imagingNon-invasive modalitySUV measurementsGastrointestinal bleedingMetabolic abnormitiesSystem abnormalitiesTotal bodyLung cancerHealthy subjectsMetabolic dysfunctionFocal lesionsCOVID-19 diseaseGlucose metabolismControl databaseSUV imagesPatientsAbnormal networkBiological mechanismsDiseasePETMetabolic connectivityPET Imaging of Synaptic Density: Challenges and Opportunities of Synaptic Vesicle Glycoprotein 2A PET in Small Animal Imaging
Toyonaga T, Fesharaki-Zadeh A, Strittmatter SM, Carson RE, Cai Z. PET Imaging of Synaptic Density: Challenges and Opportunities of Synaptic Vesicle Glycoprotein 2A PET in Small Animal Imaging. Frontiers In Neuroscience 2022, 16: 787404. PMID: 35345546, PMCID: PMC8957200, DOI: 10.3389/fnins.2022.787404.Peer-Reviewed Original ResearchAnimal modelsPET imaging studiesPET imagingImaging studiesSynaptic vesicle glycoprotein 2ADisease animal modelsOngoing clinical investigationsDifferent injection routesSynaptic densityClinical investigationPharmacological effectsRodent brainNovel interventionsInjection routeNeurodegenerative disordersNeuropsychiatric diseasesPET studiesBrainMultiple diseasesPET centersDiseaseInjectable volumeImagingSmaller brainsPET
2021
Generation of parametric Ki images for FDG PET using two 5‐min scans
Wu J, Liu H, Ye Q, Gallezot J, Naganawa M, Miao T, Lu Y, Chen M, Esserman DA, Kyriakides TC, Carson RE, Liu C. Generation of parametric Ki images for FDG PET using two 5‐min scans. Medical Physics 2021, 48: 5219-5231. PMID: 34287939, DOI: 10.1002/mp.15113.Peer-Reviewed Original ResearchConceptsPopulation-based input functionDynamic FDG-PET scansFDG-PET scansFDG-PETSUV changesPET scansClinical practiceSolid lung nodulesClinical usefulnessLate scansBone marrowRegion of interestLung nodulesInput functionScansPatlak analysisKi imagesMin/T-testCorrelation coefficientTumorsSubjectsNodulesDynamic imagingPETChapter 15 Positron emission tomography imaging agents for evaluating the pathologic features of Alzheimer's disease and drug development
Huang Y, Jia H, Bao W. Chapter 15 Positron emission tomography imaging agents for evaluating the pathologic features of Alzheimer's disease and drug development. 2021, 367-412. DOI: 10.1016/b978-0-12-816475-4.00013-6.Peer-Reviewed Original ResearchAlzheimer's diseasePathologic featuresApplication of PETDrug developmentSynaptic vesicle protein 2ADifferent pathologic featuresFeatures of neurodegenerationCentral nervous systemAD drug developmentPositron emission tomographyNeuroinflammation biomarkersCholinergic systemΒ-amyloidNervous systemTau proteinEmission tomographyAD researchDiseaseProtein 2AInvestigation of diseasesQuantitative imaging techniquesTomographyImaging techniquesAgentsPET
2019
Fluorodeoxyglucose PET for Monitoring Response to Embolotherapy (Transarterial Chemoembolization) in Primary and Metastatic Liver Tumors
Schobert I, Chapiro J, Pucar D, Saperstein L, Savic LJ. Fluorodeoxyglucose PET for Monitoring Response to Embolotherapy (Transarterial Chemoembolization) in Primary and Metastatic Liver Tumors. PET Clinics 2019, 14: 437-445. PMID: 31472741, DOI: 10.1016/j.cpet.2019.06.008.Peer-Reviewed Original ResearchMeSH KeywordsAgedCarcinoma, HepatocellularChemoembolization, TherapeuticFemaleFluorodeoxyglucose F18HumansInfusions, Intra-ArterialLiver NeoplasmsMagnetic Resonance ImagingMaleMiddle AgedMonitoring, PhysiologicMultimodal ImagingNeoplasm MetastasisPositron-Emission TomographyRadiopharmaceuticalsSensitivity and SpecificitySurvival AnalysisTomography, X-Ray ComputedTreatment OutcomeTumor MicroenvironmentConceptsTransarterial chemoembolizationLiver tumorsFluorine-18 fluorodeoxyglucose PETEfficacy of embolotherapyCross-sectional imaging techniquesMetastatic liver tumorsCancer cell glycolysisLocal recurrenceFluorodeoxyglucose PETTumor necrosisLiver cancerMorphologic changesCell glycolysisEmbolotherapyTumorsMonitoring responseIndividual molecular characteristicsMolecular characteristicsImaging techniquesChemoembolizationResponsePatientsRecurrencePETTherapyPET-Based Imaging of Ischemic Heart Disease
Chen K, Miller EJ, Sadeghi MM. PET-Based Imaging of Ischemic Heart Disease. PET Clinics 2019, 14: 211-221. PMID: 30826019, PMCID: PMC6426655, DOI: 10.1016/j.cpet.2018.12.003.Peer-Reviewed Original ResearchMeSH KeywordsComputed Tomography AngiographyCoronary Artery DiseaseCoronary CirculationCost-Benefit AnalysisFractional Flow Reserve, MyocardialHumansMultimodal ImagingMyocardial IschemiaMyocardial Perfusion ImagingPositron-Emission TomographyPrognosisRadiopharmaceuticalsSensitivity and SpecificityTomography, Emission-Computed, Single-PhotonConceptsIschemic heart diseaseHeart diseaseCoronary artery diseaseCardiac nuclear imagingCoronary flow reserveAtherosclerotic plaque vulnerabilityMyocardial blood flowCT myocardial perfusionArtery diseaseIschemic cardiomyopathyMicrovascular diseaseVascular calcificationFlow reserveVascular remodelingMyocardial viabilityPlaque vulnerabilityBlood flowMyocardial perfusionMolecular imaging toolDiseaseNuclear imagingImaging toolPETImagingPrognosis
2018
Superior Pituitary Border Analysis in Immunotherapy-Induced Hypophysitis
Pucar D, Boustani AM, Bronen RA, Saperstein L. Superior Pituitary Border Analysis in Immunotherapy-Induced Hypophysitis. Clinical Nuclear Medicine 2018, 43: 284-286. PMID: 29401149, DOI: 10.1097/rlu.0000000000001981.Peer-Reviewed Educational MaterialsConceptsSinus diseasePituitary swellingSevere headacheVisual disturbancesLaboratory findingsMetastatic melanomaPituitary abnormalitiesRetrospective analysisContrast CTNoncontrast CTPituitary hormonesHypophysitisHeadacheDiseaseDiagnosisCTLow levelsNivolumabHypermetabolismImmunotherapyPETMelanomaAbnormalitiesFindingsHormone
2017
Pet ownership increases human risk of encountering ticks
Jones E, Hinckley A, Hook S, Meek J, Backenson B, Kugeler K, Feldman K. Pet ownership increases human risk of encountering ticks. Zoonoses And Public Health 2017, 65: 74-79. PMID: 28631423, PMCID: PMC7053298, DOI: 10.1111/zph.12369.Peer-Reviewed Original ResearchPET Imaging for Early Detection of Alzheimer’s Disease From Pathologic to Physiologic Biomarkers
Bao W, Jia H, Finnema S, Cai Z, Carson RE, Huang YH. PET Imaging for Early Detection of Alzheimer’s Disease From Pathologic to Physiologic Biomarkers. PET Clinics 2017, 12: 329-350. PMID: 28576171, DOI: 10.1016/j.cpet.2017.03.001.Peer-Reviewed Original Research
2015
Synergistic role of simultaneous PET/MRI-MRS in soft tissue sarcoma metabolism imaging
Zhang X, Chen Y, Lim R, Huang C, Chebib I, Fakhri G. Synergistic role of simultaneous PET/MRI-MRS in soft tissue sarcoma metabolism imaging. Magnetic Resonance Imaging 2015, 34: 276-279. PMID: 26523656, PMCID: PMC4761342, DOI: 10.1016/j.mri.2015.10.027.Peer-Reviewed Original ResearchConceptsSoft tissue sarcomasMagnetic resonance imagingHigh (18)F-FDG uptakeT2 hyperintense massMagnetic resonance spectroscopyNeoadjuvant radiotherapyPathological resultsTumor marginsTissue sarcomasImaging findingsPET/MRI scansPET scansRight thighRadiotherapyNormal tissuesEmission tomographyResonance imagingMetabolite profilesSarcomaPET/MRIChemoRTChemoradiationSynergistic rolePETSurgery
2014
Test-retest variability of adenosine A2A binding in the human brain with 11C-TMSX and PET
Naganawa M, Mishina M, Sakata M, Oda K, Hiura M, Ishii K, Ishiwata K. Test-retest variability of adenosine A2A binding in the human brain with 11C-TMSX and PET. EJNMMI Research 2014, 4: 76. PMID: 25621197, PMCID: PMC4293456, DOI: 10.1186/s13550-014-0076-9.Peer-Reviewed Original ResearchTest-retest variabilityCerebral cortexCentrum semiovaleMethodsFive healthy volunteersNon-displaceable uptakeLow test-retest variabilityReference regionArterial blood samplingTest-retest reproducibilityCandidate reference regionsHuman brainTest-retest studyHealthy volunteersAdenosine A2ABlood samplingDistribution volumeInvasive methodNoninvasive methodReceptor quantificationBPNDCortexBrainPresent studySimilar levelsPETDiffuse Renal 18F-FDG Uptake of a Patient With Fever of Unknown Origin Revealed Sarcoidosis
Toyonaga T, Manabe O, Gaertner FC, Nakagaki T, Nishio S, Suzuki A, Tamaki N. Diffuse Renal 18F-FDG Uptake of a Patient With Fever of Unknown Origin Revealed Sarcoidosis. Clinical Nuclear Medicine 2014, 39: 648-649. PMID: 24873783, DOI: 10.1097/rlu.0000000000000488.Peer-Reviewed Original ResearchConceptsFDG uptakeFDG-PETAbnormal FDG uptakeGranulomatous interstitial nephritisImprovement of symptomsF-FDG PETRenal biopsy samplesTherapy response evaluationRenal sarcoidosisAcute deteriorationRenal functionInterstitial nephritisMethylprednisolone treatmentHistopathologic examinationBiopsy samplesTreatment efficacySarcoidosisResponse evaluationPETUptakeNephritisPatientsRenalFeverAnemia
2013
How to Study Smoking and Drinking with PET
Morris E, Lucas M, Cosgrove K. How to Study Smoking and Drinking with PET. 2013 DOI: 10.5772/57414.Peer-Reviewed Original ResearchSmokingPETProton Therapy Verification with PET Imaging
Zhu X, Fakhri G. Proton Therapy Verification with PET Imaging. Theranostics 2013, 3: 731-740. PMID: 24312147, PMCID: PMC3840408, DOI: 10.7150/thno.5162.Peer-Reviewed Original Research
2008
SU‐GG‐I‐74: New IAEA Document On Acceptance Testing, Quality Assurance and Quality Control for PET and PET/CT Systems
Fakhri G, Fulton R, Gray J, Marengo M, Zimmerman B, Dondi M, McLean I, Palm S. SU‐GG‐I‐74: New IAEA Document On Acceptance Testing, Quality Assurance and Quality Control for PET and PET/CT Systems. Medical Physics 2008, 35: 2659-2659. DOI: 10.1118/1.2961472.Peer-Reviewed Original ResearchPET/CT scannerTime-of-flight systemDetector materialPET/CTPET/CT unitComputed tomographyPET indicatorPET/CT systemCT componentPET technologyCT dataNatural radioactivityLesion detectionRadioactivity concentrationPETQuality assuranceDefinition of applicationsIAEAIAEA documentsGuidelinesAcceptance testsReference valuesScannerLesionsDetector
2007
Clinical Myocardial Perfusion PET/CT
Di Carli M, Dorbala S, Meserve J, Fakhri G, Sitek A, Moore S. Clinical Myocardial Perfusion PET/CT. Journal Of Nuclear Medicine 2007, 48: 783-793. PMID: 17475968, DOI: 10.2967/jnumed.106.032789.Peer-Reviewed Original ResearchConceptsCoronary artery diseaseMyocardial perfusion PETPerfusion PETDiagnosing obstructive CADClinically useful risk stratificationObstructive coronary artery diseaseAnatomic coronary artery diseaseMyocardial perfusion PET/CTMultivessel coronary artery diseaseLeft ventricular functionEvaluation of patientsQuantify myocardial perfusionVentricular functionIschemic burdenPharmacological stressRisk stratificationCardiac PETArtery diseasePET/CT technologyMyocardial perfusionAttenuation correctionNuclear cardiologyFunctional consequencesSPECTPET
2003
Evaluation of a Monte Carlo Scatter Correction in Clinical 3D PET
Holdsworth C, Badawi R, Santos P, Van den Abbeele A, Hoffman E, Fakhri G. Evaluation of a Monte Carlo Scatter Correction in Clinical 3D PET. 2003, 4: 2540-2544. DOI: 10.1109/nssmic.2003.1352408.Peer-Reviewed Original ResearchScatter correctionUncorrected imagesPET imagingChannelized Hotelling observerHotelling observerPatient dataPatient imagesQuantitative accuracyLesion detection sensitivityPatient sizePhantomLesion sensitivityPatientsMonteLesionsLesion detectionCorrectionROI analysisIntensity varianceDetection sensitivityPETScatteringAverage absolute bias
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply